FDA approves Lilly's new migraine attack drug, rival from Al...

The FDA has approved Eli Lilly’s new migraine drug lasmiditan, offering patients a new option to relieve symptoms should they feel an attack coming on.

Humira tops list of drugs with unwarranted US price hikes

Xeris’ severe low blood sugar pen gets FDA approval

Relief for Lilly as drug from $8bn Loxo deal clears pivotal ...

Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimt...

Roche's CMO Horning to retire, Lilly's high-flyer Garraway s...

Roche’s influential chief medical officer Sandra Horning is to retire at the end of the year, the company has confirmed, to be replaced by a high-flyer from rival Eli Lilly.